Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China · Delayed Price · Currency is CNY 4.540
-0.240 (-5.02%)
May 21, 2026, 3:04 PM CST
SHE:002581 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -178.21 | -160.83 | -137.31 | -332.46 | -14.68 | 271 |
Depreciation & Amortization | 38.49 | 38.49 | 41.67 | 70.63 | 74.86 | 65.9 |
Other Amortization | 0.15 | 0.15 | 1.09 | 4.41 | 2.59 | 3.55 |
Loss (Gain) From Sale of Assets | -3.82 | -3.82 | -1.16 | 6.33 | -0.05 | 0.15 |
Asset Writedown & Restructuring Costs | 43.65 | 43.65 | 69.64 | 293.88 | 13.61 | 0.48 |
Loss (Gain) From Sale of Investments | -23.91 | -23.91 | -44.08 | -172.68 | -217.45 | -471.94 |
Provision & Write-off of Bad Debts | - | - | -4.73 | -27.56 | -3.48 | -2.2 |
Other Operating Activities | 63.41 | 17.96 | 10.02 | 39.07 | 22.87 | 21.01 |
Change in Accounts Receivable | -230.18 | -230.18 | 67.81 | 69.76 | 2.45 | 75.08 |
Change in Inventory | 20.82 | 20.82 | -9.34 | -15.16 | -16.13 | 6.53 |
Change in Accounts Payable | 30.57 | 30.57 | 11.35 | 6.24 | 68.51 | -15.39 |
Change in Other Net Operating Assets | 29.28 | 29.28 | -8.31 | 15.5 | - | - |
Operating Cash Flow | -225.66 | -253.73 | -6.55 | -36.51 | -54.49 | -46.02 |
Capital Expenditures | -189.22 | -179.7 | -9.01 | -4.32 | -31.46 | -60.85 |
Sale of Property, Plant & Equipment | 1.62 | 4.07 | 8.17 | 4.77 | 24.45 | 0.02 |
Divestitures | - | - | 73.75 | - | - | - |
Investment in Securities | - | - | - | 0.03 | -28 | 5 |
Other Investing Activities | 143.02 | 143.02 | 294.16 | 256.17 | -3.4 | - |
Investing Cash Flow | -44.58 | -32.61 | 367.06 | 256.65 | -38.42 | -55.83 |
Short-Term Debt Issued | - | - | - | - | 227.5 | 218 |
Long-Term Debt Issued | - | 8 | 2.77 | 13.84 | 62.95 | - |
Total Debt Issued | 37 | 8 | 2.77 | 13.84 | 290.45 | 218 |
Short-Term Debt Repaid | - | - | - | - | -229 | -188 |
Long-Term Debt Repaid | - | -19.78 | -10.56 | -214.7 | -13.39 | -25.3 |
Total Debt Repaid | -62.55 | -19.78 | -10.56 | -214.7 | -242.39 | -213.3 |
Net Debt Issued (Repaid) | -25.55 | -11.78 | -7.79 | -200.87 | 48.06 | 4.7 |
Common Dividends Paid | -1.64 | -1.14 | -0.18 | -10.28 | -8.04 | -6.71 |
Other Financing Activities | -1.01 | -1.12 | - | - | 7.88 | 7.49 |
Financing Cash Flow | -28.19 | -14.03 | -7.97 | -211.14 | 47.89 | 5.49 |
Foreign Exchange Rate Adjustments | -0 | -0 | 0 | -0 | 0 | -0 |
Net Cash Flow | -298.44 | -300.37 | 352.54 | 9 | -45 | -96.35 |
Free Cash Flow | -414.88 | -433.43 | -15.56 | -40.82 | -85.95 | -106.86 |
Free Cash Flow Margin | -146.43% | -157.72% | -4.32% | -9.50% | -24.07% | -26.53% |
Free Cash Flow Per Share | -0.63 | -0.66 | -0.02 | -0.06 | -0.13 | -0.16 |
Cash Income Tax Paid | 15.11 | 15.63 | 22.6 | 31.75 | 15.49 | 20.31 |
Levered Free Cash Flow | -335.29 | -337.55 | 32.36 | -107.84 | 85.69 | 1.83 |
Unlevered Free Cash Flow | -335.29 | -337.55 | 32.49 | -102.18 | 91.57 | 6.13 |
Change in Working Capital | -165.42 | -165.42 | 58.32 | 81.88 | 67.26 | 66.03 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.